Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

HOMER E BRECKENRIDGE

Allopathic & Osteopathic Physicians Surgery

NPI
1649371790
CMS profile
29032
Location
DONALSONVILLE, GA

General Payments · PY2018–2024

$2,241.11

  • Reported across 110 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$208.76

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $208.76 11

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $110.35 6
GlaxoSmithKline, LLC. $64.18 3
Boehringer Ingelheim Pharmaceuticals, Inc. $34.23 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $103.24 6
PY2019 $403.56 8
PY2020 $217.96 13
PY2021 $421.32 26
PY2022 $619.03 31
PY2023 $267.24 15
PY2024 $208.76 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $16.61 04/24/2024 Food and Beverage Undisputed 01/23/2026 1118094376 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.62 08/14/2024 Food and Beverage Undisputed 01/23/2026 1118094378 CMS
GlaxoSmithKline, LLC. $29.97 01/15/2024 Food and Beverage Undisputed 01/23/2026 1116583793 CMS
GlaxoSmithKline, LLC. $18.37 07/16/2024 Food and Beverage Undisputed 01/23/2026 1116288825 CMS
GlaxoSmithKline, LLC. $15.84 11/21/2024 Food and Beverage Undisputed 01/23/2026 1116313497 CMS
Novo Nordisk Inc $18.29 01/16/2024 Food and Beverage Undisputed 01/23/2026 1097109092 CMS
Novo Nordisk Inc $15.68 04/23/2024 Food and Beverage Undisputed 01/23/2026 1097677967 CMS
Novo Nordisk Inc $19.79 06/25/2024 Food and Beverage Undisputed 01/23/2026 1097591317 CMS
Novo Nordisk Inc $18.29 07/30/2024 Food and Beverage Undisputed 01/23/2026 1096655126 CMS
Novo Nordisk Inc $18.70 08/07/2024 Food and Beverage Undisputed 01/23/2026 1096613228 CMS
Novo Nordisk Inc $19.60 09/16/2024 Food and Beverage Undisputed 01/23/2026 1097316388 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.